Habermann, B; Eberhardt, C; Hovy, L et al.
Total hip replacement in patients with severe bleeding disorders : A 30 years single center experience.Int Orthop. Bd. 31. H. 1. 2007 S. 17-21
Warger, T; Rechtsteiner, G; Schmid, B et al.
Transcutaneous Immunization With Imiquimod Is Amplified by CD40 Ligation and Results in Sustained Cytotoxic T-Lymphocyte Activation and Tumor Protection.Clin Rev Allergy Immunol. Bd. 32. H. 1. 2007 S. 57-66
Sebastian, M; Passlick, B; Friccius-Quecke, H et al.
Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study.Cancer Immunol Immunother. Bd. 56. H. 10. 2007 S. 1637-44
Borel-Derlon, A; Federici, AB; Roussel-Robert, V et al.
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients.J Thromb Haemost. Bd. 5. H. 6. 2007 S. 1115-24
Haselmayer, P; Grosse-Hovest, L; von Landenberg, P et al.
TREM-1 ligand expression on platelets enhances neutrophil activation.Blood. Bd. 110. H. 3. 2007 S. 1029-35
Giles, F; Fischer, T; Cortes, J et al.
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies.Clin Cancer Res. Bd. 12. H. 15. 2006 S. 4628-35
Schmittel, A; Fischer von Weikersthal, L; Sebastian, M et al.
A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer.Ann Oncol. Bd. 17. H. 4. 2006 S. 663-7
Wassmann, B; Pfeifer, H; Goekbuget, N et al.
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).Blood. Bd. 108. H. 5. 2006 S. 1469-77
Glasmacher, A; Cornely, O; Ullmann, AJ et al.
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.J Antimicrob Chemother. Bd. 57. H. 2. 2006 S. 317-25
Ullmann, AJ; Cornely, OA
Antifungal prophylaxis for invasive mycoses in high risk patients.Curr Opin Infect Dis. Bd. 19. H. 6. 2006 S. 571-6